Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sharkey

Showing results (471-480 of 506) with videos related to

Pageof 51
Sort By:
Trends in Pharmacological Sciences|March 23, 2015
Endocannabinoid signaling at the periphery: 50 years after THCMauro Maccarrone, Itai Bab, Tamás Bíró, et al.
British Journal of Pharmacology|October 1, 2010
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodentsN L Cluny, V K Vemuri, A P Chambers, et al.
Neurogastroenterology and Motility|February 7, 2004
The expression and role of Fas ligand in intestinal inflammationF A Sayani, C M Keenan, M D Van Sickle, et al.
Frontiers in Cellular Neuroscience|December 17, 2021
Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male MiceHaley A Vecchiarelli, Robert J Aukema, Catherine Hume, et al.
Inflammatory Bowel Diseases|July 12, 2011
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentRudolf Schicho, Mohammad Bashashati, Misha Bawa, et al.
Gastroenterology|June 10, 2004
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndromeMatthew D Coates, Christine R Mahoney, David R Linden, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptorsMartin A Storr, Catherine M Keenan, Dominik Emmerdinger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 13, 2005
Adjusting data to body size: a comparison of methods as applied to quantitative trait loci analysis of musculoskeletal phenotypesDean H Lang, Neil A Sharkey, Arimantas Lionikas, et al.
Cannabis and Cannabinoid Research|September 15, 2022
Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal IntegrityChristopher D Drummond-Main, Younghee Ahn, Mitchell Kesler, et al.
Brain, Behavior, and Immunity|March 8, 2022
Colitis-associated microbiota drives changes in behaviour in male mice in the absence of inflammationFernando A Vicentini, Jake C Szamosi, Laura Rossi, et al.
Pageof 51

Showing results (471-480 of 506) with videos related to

Sort By:
Pageof 51
Trends in Pharmacological Sciences|March 23, 2015
Endocannabinoid signaling at the periphery: 50 years after THCMauro Maccarrone, Itai Bab, Tamás Bíró, et al.
British Journal of Pharmacology|October 1, 2010
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodentsN L Cluny, V K Vemuri, A P Chambers, et al.
Neurogastroenterology and Motility|February 7, 2004
The expression and role of Fas ligand in intestinal inflammationF A Sayani, C M Keenan, M D Van Sickle, et al.
Frontiers in Cellular Neuroscience|December 17, 2021
Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male MiceHaley A Vecchiarelli, Robert J Aukema, Catherine Hume, et al.
Inflammatory Bowel Diseases|July 12, 2011
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentRudolf Schicho, Mohammad Bashashati, Misha Bawa, et al.
Gastroenterology|June 10, 2004
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndromeMatthew D Coates, Christine R Mahoney, David R Linden, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 22, 2008
Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptorsMartin A Storr, Catherine M Keenan, Dominik Emmerdinger, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 13, 2005
Adjusting data to body size: a comparison of methods as applied to quantitative trait loci analysis of musculoskeletal phenotypesDean H Lang, Neil A Sharkey, Arimantas Lionikas, et al.
Cannabis and Cannabinoid Research|September 15, 2022
Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal IntegrityChristopher D Drummond-Main, Younghee Ahn, Mitchell Kesler, et al.
Brain, Behavior, and Immunity|March 8, 2022
Colitis-associated microbiota drives changes in behaviour in male mice in the absence of inflammationFernando A Vicentini, Jake C Szamosi, Laura Rossi, et al.
Pageof 51